Location History:
- Paris Cedex, FR (1999)
- Vanves, FR (1993 - 2012)
Company Filing History:
9 out of 5,089 
7 out of 154 
5 out of 1,744 
Years Active: 1993-2012
Title: Sylvie Robine: Innovator in Cancer Therapy
Introduction
Sylvie Robine is a prominent inventor based in Vanves, France, known for her significant contributions to cancer therapy and diagnosis. With a total of 10 patents to her name, she has made remarkable strides in the field of medical research.
Latest Patents
Her latest patents focus on innovative compounds for cancer therapy and diagnosis. One notable invention involves the use of a non-toxic B subunit of Shiga toxin mutant as a vector for diagnostic products or drugs targeting over-expressing GB3 receptor cells. The compounds she developed have the formula: STxB-Z(n)-Cys-Y(m)-T. This invention aims to enhance tumor diagnosis and drug delivery to GB3 expressing tumors, showcasing her commitment to advancing cancer treatment.
Career Highlights
Throughout her career, Sylvie has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Institut Curie. Her work in these institutions has allowed her to collaborate with leading experts in the field, furthering her research and innovation.
Collaborations
Some of her notable coworkers include Daniel Louvard and Ludger Johannes, who have contributed to her research endeavors and helped in the development of her groundbreaking inventions.
Conclusion
Sylvie Robine's work in cancer therapy and diagnosis exemplifies her dedication to improving medical outcomes through innovation. Her patents and collaborations reflect her significant impact on the field, making her a key figure in the fight against cancer.